HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a response View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Holly, E A Articles by Bracci, P M Search for Related Content PubMed PubMed Citation Articles by Holly, E A Articles by Bracci, P M

Hair-color products and risk for non-Hodgkin's lymphoma: a population-based study in the San Francisco bay area.

E A Holly, C Lele and P M Bracci

Department of Epidemiology and Biostatistics, School of Medicine, University of California, San Francisco, USA.

OBJECTIVES: As part of a large, epidemiologic study of non-Hodgkin's lymphoma, this study investigated a possible association between use of hair-color products and non-Hodgkin's lymphoma. METHODS: A population-based case-control study was conducted in the San Francisco Bay area. Of 4108 participants, 2544 were questioned about use of hair-color products. Control subjects were identified by use of random-digit dialing. RESULTS: Ever use of hair-color products was reported by 56% of case and 56% of control women and 10% of case and 9% of control men. Risks were not elevated for women for use of any hair-color products. Men who ever used semipermanent hair color had slightly elevated risks for non-Hodgkin's lymphoma, with trends associated with greater lifetime frequency of use and frequency of use per year, although individual confidence intervals overlapped unity. These elevated risks were diminished with exclusive use of semipermanent products, and confidence intervals overlapped unity. CONCLUSIONS: Integration of our results with those from experimental animal studies and other epidemiologic studies provides little convincing evidence linking non-Hodgkin's lymphoma with normal use of hair-color products in humans.

This article has been cited by other articles:

				Y. Zhang, S. D. Sanjose, P. M. Bracci, L. M. Morton, R. Wang, P. Brennan, P. Hartge, P. Boffetta, N. Becker, M. Maynadie, et al. Personal Use of Hair Dye and the Risk of Certain Subtypes of Non-Hodgkin Lymphoma Am. J. Epidemiol., June 1, 2008; 167(11): 1321 - 1331. [Abstract] [Full Text] [PDF]

				C. F. Skibola, A. Nieters, P. M. Bracci, J. D. Curry, L. Agana, D. R. Skibola, A. Hubbard, N. Becker, M. T. Smith, and E. A. Holly A functional TNFRSF5 gene variant is associated with risk of lymphoma Blood, April 15, 2008; 111(8): 4348 - 4354. [Abstract] [Full Text] [PDF]

				L. M. Morton, L. Bernstein, S. S. Wang, D. W. Hein, N. Rothman, J. S. Colt, S. Davis, J. R. Cerhan, R. K. Severson, R. Welch, et al. Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma Carcinogenesis, August 1, 2007; 28(8): 1759 - 1764. [Abstract] [Full Text] [PDF]

				E. C. Bluhm, S. H. Zahm, H. A. Fine, P. M. Black, J. S. Loeffler, W. R. Shapiro, R. G. Selker, and P. D. Inskip Personal Hair Dye Use and Risks of Glioma, Meningioma, and Acoustic Neuroma among Adults Am. J. Epidemiol., January 1, 2007; 165(1): 63 - 71. [Abstract] [Full Text] [PDF]

				P. M. Bracci, T. B. Dalvi, and E. A. Holly Residential history, family characteristics and non-hodgkin lymphoma, a population-based case-control study in the san francisco bay area. Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1287 - 1294. [Abstract] [Full Text] [PDF]

				S. de Sanjose, Y. Benavente, A. Nieters, L. Foretova, M. Maynadie, P. L. Cocco, A. Staines, M. Vornanen, P. Boffetta, N. Becker, et al. Association between Personal Use of Hair Dyes and Lymphoid Neoplasms in Europe Am. J. Epidemiol., July 1, 2006; 164(1): 47 - 55. [Abstract] [Full Text] [PDF]

				C. A. Clarke, D. M. Undurraga, P. J. Harasty, S. L. Glaser, L. M. Morton, and E. A. Holly Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and study. Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 630 - 638. [Abstract] [Full Text] [PDF]

				Y. Benavente, N. Garcia, E. Domingo-Domenech, T. Alvaro, R. Font, Y. Zhang, and S. de Sanjose Regular use of hair dyes and risk of lymphoma in Spain Int. J. Epidemiol., October 1, 2005; 34(5): 1118 - 1122. [Abstract] [Full Text] [PDF]

				B. Takkouche, M. Etminan, and A. Montes-Martinez Personal Use of Hair Dyes and Risk of Cancer: A Meta-analysis JAMA, May 25, 2005; 293(20): 2516 - 2525. [Abstract] [Full Text] [PDF]

				D. R. Skibola, M. T. Smith, P. M. Bracci, A. E. Hubbard, L. Agana, S. Chi, and E. A. Holly Polymorphisms in Ghrelin and Neuropeptide Y Genes Are Associated with Non-Hodgkin Lymphoma Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1251 - 1256. [Abstract] [Full Text] [PDF]

				C. F. Skibola, M. S. Forrest, F. Coppede, L. Agana, A. Hubbard, M. T. Smith, P. M. Bracci, and E. A. Holly Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma Blood, October 1, 2004; 104(7): 2155 - 2162. [Abstract] [Full Text] [PDF]

				C. F. Skibola, E. A. Holly, M. S. Forrest, A. Hubbard, P. M. Bracci, D. R. Skibola, C. Hegedus, and M. T. Smith Body Mass Index, Leptin and Leptin Receptor Polymorphisms, and Non-Hodgkin Lymphoma Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 779 - 786. [Abstract] [Full Text] [PDF]

				Y. Zhang, T. R. Holford, B. Leaderer, P. Boyle, S. H. Zahm, S. Flynn, G. Tallini, P. H. Owens, and T. Zheng Hair-coloring Product Use and Risk of Non-Hodgkin's Lymphoma: A Population-based Case-Control Study in Connecticut Am. J. Epidemiol., January 15, 2004; 159(2): 148 - 154. [Abstract] [Full Text] [PDF]

				C. A. Clarke, S. L. Glaser, R. F. Dorfman, P. M. Bracci, E. Eberle, and E. A. Holly Expert Review of Non-Hodgkin's Lymphomas in a Population-Based Cancer Registry: Reliability of Diagnosis and Subtype Classifications Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 138 - 143. [Abstract] [Full Text] [PDF]

				E. A. Holly and P. M. Bracci Population-based Study of Non-Hodgkin Lymphoma, Histology, and Medical History among Human Immunodeficiency Virus-negative Participants in San Francisco Am. J. Epidemiol., August 15, 2003; 158(4): 316 - 327. [Abstract] [Full Text] [PDF]

				A. B. Beiderbeck, E. A. Holly, M. C. J. M. Sturkenboom, J. W. W. Coebergh, B. H. Ch. Stricker, and H. G. M. Leufkens Prescription Medications Associated with a Decreased Risk of Non-Hodgkin's Lymphoma Am. J. Epidemiol., March 15, 2003; 157(6): 510 - 516. [Abstract] [Full Text] [PDF]

				E. J. Chow and E. A. Holly Blood Transfusions and Non-Hodgkin's Lymphoma Epidemiol. Rev., December 1, 2002; 24(2): 269 - 279. [Full Text] [PDF]

				E. J. Chow and E. A. Holly Blood Transfusions as a Risk Factor for Non-Hodgkin's Lymphoma in the San Francisco Bay Area: A Population-based Study Am. J. Epidemiol., April 15, 2002; 155(8): 725 - 731. [Abstract] [Full Text] [PDF]

				J. M. Vose, B. C.-H. Chiu, B. D. Cheson, J. Dancey, and J. Wright Update on Epidemiology and Therapeutics for Non-Hodgkin's Lymphoma Hematology, January 1, 2002; 2002(1): 241 - 262. [Abstract] [Full Text]

				F. D. Groves, M. S. Linet, L. B. Travis, and S. S. Devesa Cancer Surveillance Series: Non-Hodgkin's Lymphoma Incidence by Histologic Subtype in the United States From 1978 Through 1995 J Natl Cancer Inst, August 2, 2000; 92(15): 1240 - 1251. [Abstract] [Full Text] [PDF]